|Articles|May 1, 2017
EAG Laboratories
Advertisement
EAG Laboratories: Complete biopharmaceutical characterization services
EAG Laboratories’ complete suite of biopharmaceutical characterization services include: Mass analysis (intact, reduced, deglycosylated); Peptite Map-UPLC-UHR QT of MS (Sequencing, PTMs, Disulfide Linkages, Chemical Modification for ADC , PEG, etc.); N-Glycan Profile-UPLC-MS, HI LIC -FL (site, extent and structure of glycosylation); and Protein structure characterization, analysis of post-translational modifications and degradants, and glycosylation analysis.
+1.800.538.5227
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
3
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
4
High-Dose Nusinersen Slows Neurodegeneration in SMA Patients, Study Shows
5